vegf delivery retrogradely transported lentivector prolongs survival mouse als model 
amyotrophic lateral sclerosis als causes adult-onset progressive motor neuron degeneration brain spinal cord resulting paralysis death three five years onset patients als still incurable part complex aetiology remains insufficiently understood recent reports indicated reduced levels vascular endothelial growth factor vegf essential angiogenesis also implicated neuroprotection- predispose mice humans als however therapeutic potential vegf treatment als previously assessed report single injection vegf-expressing lentiviral vector various muscles delayed onset slowed progression als mice engineered overexpress gene coding mutated g93a form superoxide dismutase sod1g93a refs even treatment initiated onset paralysis vegf treatment increased life expectancy als mice per cent without causing toxic side effects thereby achieving one effective therapies reported field far 
